Dr Zolman's Work
Longevity School
50 hours online training by Dr Zolman for individuals (available 2025) and clinicians (2026). Peer-reviewed + seeking accreditation & insurance coverage.
Dr Zolman created a new medical specialty (LEVMED) with its own peer-reviewed AGREE2/IPDAS compliant clinical practice guidelines around the Longevity Level 123 protocol, to test if it outperforms standard care and achieves LEV. Pseudoscience free.
Dr Zolman's Guideline-Approved Health Calculators
Get your personalised recommendations, based on international clinical guidelines (highest form of evidence in medicine).
Triple Helix - Gene Therapies
Dr Zolman leads Longevity Science at the world's most advanced experimental consumer longevity gene therapy program. www.3xhelix.com
Project MouseSpan
We are funding key mouse lifespan studies that can transform the cutting-edge of longevity medicine, aiming to break the Mouse Lifespan world-record multiple times. www.MouseSpan.com
Collagen Clinic London (Harley Street) - at London Longevity Clinic
Dr Zolman wants your skin to look & be 25% younger across your entire body. Using the world's most advanced skin quantification service and rejuvenation therapies. www.CollagenClinic.London
The Longevity Leaderboards
Dr Zolman created the field of evidence-based competitive rejuvenation, through the Zolman Rejuvenation Leaderboards on his website (in update).
Level 1, 2, 3 Longevity Protocol
Dr Zolman created the Level 1, 2, 3 protocol to integrate all current & future aging tests and therapies as a single personalised adaptive health protocol to prove N=1 rejuvenation in all organs, which is taught in Longevity School.
The 81 Organ Framework & Zolman Clocks
Dr Zolman created the concept of measuring aging in all 81 organ types, using Zolman Clocks, with biostatistical rigour (publications pending) to prove rejuvenation & N=1 LEV.
Rejuvenation Olympics (Defunct)
Dr Zolman created rejuvenationolympics.com however the rules changed for marketing purposes and it now holds little scientific validity.
Founder Project Blueprint (Defunct)
Dr Zolman used his Longevity Level 123 protocol on his client Bryan Johnson, called 'Project Blueprint'.
Specialist Consultancy in Experimental Evidence-Based Rejuvenation.
20one Consulting aim to be the first to prove N=1 Longevity Escape Velocity, through rigorously peer-reviewed studies, including showing evidence individuals are 25% younger in all 81 organ types & multi-organ clocks by 2030.
The Longevity Level 1, 2, 3 framework was made to integrate all evidence-based longevity tests & therapies, including pre-commercial ones, into a single, adaptive, personalised experimental protocol
The protocol provides the maximum theoretical chance of reaching age 100+ in good health compared to any other health protocol globally given it is a 'meta' protocol/guideline that incorporates all others
Longevity Level 1
Maintaining Level 1 from a young age *may* give an average person an age 90+ life expectancy, with high healthspan. As based on predominantly retrospective epidemiological data.
Longevity Level 2
Completing Level 2 *may* give the average person increased quality of life up to age 75, but likely has insufficient evidence for increasing life expectancy beyond this age in people already doing Level 1.
Longevity Level 3
Level 3 therapies are theoretically likely required to have higher certainty of being healthy past age 70
Level 3 includes tests and therapies
Tests: Measure biological age accurately in each of the 81 organ types in individuals, as well as multi-organ biological age tests. Biostatistical accuracy is according to peer-reviewed Zolman Biological Age Marker Criteria (Z-BAM) (currently under NDA) with a strict biostatistical testing methodology.
Therapies: Use of all existing clinical practice guidelines for ageing conditions across all medical specialties is included in Level 3, e.g. statins, blood pressure medication, or cardiac or cancer surgery, with the additional use of further Level 3 Therapy Experimental Clinical Practice Guidelines for therapies that lack sufficiently good guidelines, all of which are AGREE-II and IPDAS compliant. Level 3 therpaies are organ or multi-organ targeted and attempt experimental reversal of the biological age of each organ in individuals.
